A deep dive into the oncology target PRMT5 with the CEO of Tango Therapeutics
Barbara Weber walks us through the science of PRMT5, shares her reaction to recent data, and describes how programs are designed differently.
Also look for unique social pages for BiotechTV U.
#1. Pfizer’s CEO on Q2 earnings.
​
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
​
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
​
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square